| Dr Malcolm A King, MDPSC | |
|
613 23rd St, Suite 230, Ashland, KY 41101-2878 | |
| (606) 324-4745 | |
| (606) 324-4941 |
| Full Name | Dr Malcolm A King |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 613 23rd St, Ashland, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770545469 | NPI | - | NPPES |
| 0085561000 | Medicaid | WV | |
| 110028144 | Other | KY | TRAVELERS MEDICARE |
| 64241953 | Medicaid | KY | |
| 000000049114 | Other | KY | ANTHEM/BLUE CROSS/BLUE SH |
| 611140483 | Other | KY | COMMERCIAL |
| K011087 | Other | KY | CHAMPUS |
| 0690542 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 24195 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Malcolm A King, MDPSC Po Box 2379, Ashland, KY 41105-2379 Ph: (606) 324-4745 | Dr Malcolm A King, MDPSC 613 23rd St, Suite 230, Ashland, KY 41101-2878 Ph: (606) 324-4745 |
News Archive
AMAG Pharmaceuticals, Inc. today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization in Switzerland for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease.
Three-year data from the prospective, randomized LEADERS trial demonstrate the equivalence of a biolimus A9-eluting stent with a biodegradable polymer vs. a sirolimus-eluting stent with a durable polymer. The results will be presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today that a review of the Company's lead compound, XMT-1001, will appear in the November 12, 2009 special issue of Advanced Drug Delivery Reviews on Polymer Therapeutics: Clinical Applications and Challenges for Development.
St. Jude Medical, Inc., a global medical device company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for expansion of its BROADEN (BROdmann Area 25 DEep brain Neurostimulation) study for depression. This expansion will allow a maximum of 20 sites across the U.S. to enroll up to 125 patients.
A simple DNA test that is available commercially to help people establish their ancestry could in fact disclose male infertility claims a new study from the University of Leicester.
› Verified 3 days ago
Padma Venkatraman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 101 Ashland Dr, Ashland, KY 41101 Phone: 606-324-1996 Fax: 606-833-2430 | |
Amr Idris, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 613 23rd St Ste 230, Ashland, KY 41101 Phone: 606-324-4745 Fax: 606-324-4941 | |
Paula K Larsen, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1000 Ashland Dr Ste G1, Ashland, KY 41101 Phone: 606-408-4900 Fax: 606-408-6643 | |
Michael Don Canty, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St, Suite 11, Ashland, KY 41101 Phone: 606-324-3188 Fax: 606-329-2237 | |
Dr. Ryann Acquino Pangan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 130, Ashland, KY 41101 Phone: 606-329-9335 Fax: 606-324-6383 | |
Dr. Francisco Fernandez-gonzalez, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 310, Ashland, KY 41101 Phone: 606-833-2161 | |
Dr. Chad Jacob Tarabolous, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St, Suite 19, Ashland, KY 41101 Phone: 606-325-2221 Fax: 606-324-1326 |